Vol. 88, Núm. 03 (2017)
Texto completo
Documento similar
Only a small number of pediatric patients with positive testing for COVID-19 were reported in this global survey: 61 with type 1 diabetes mellitus and 25 with type 2... Their
BRS-3 seems to play a role in glucose metabolism, not only in normal subjects, but also in obese patients and patients with T2D. Furthermore, its ligand is capable of improving
Efficacy and safety of atorvastatin in the prevention of cardiovascular end points in subjects with type 2 diabetes: the Atorvastatin Study for Prevention of Coronary Heart
In the hypothalamus this transporter is located in astrocytes, ependymal cells, tanycytes and glucose-sensitive neurons [41,42,113–115] and it is essential for central glucose
Sources of data for analysis included study-level data from the Cohorts for Heart and Aging Research in Genomic Epidemiology Birth Gene (CHARGE-BIG) Study (49 studies, n = 180
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy (CREDENCE), Dapagliflozin on Renal Outcomes and Cardiovascular Mortality in Patients with Chronic Kidney
Type 2 diabetes, type 2 diabetes adjusted for BMI, fasting glucose, fasting glucose adjusted for BMI, fasting insulin, fasting insulin adjusted for BMI, diastolic blood
In summary, transcriptome analysis of SCA1 mice (transgenic and knock-in) and flies support the idea of impairment of glucose uptake and abnormal glucose metabolism during